Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Arch Sex Behav. 2020 Jan 16;49(6):1887–1902. doi: 10.1007/s10508-019-01581-1

Table 3.

Factors associated with seeing a medical doctor in response to potential STI symptoms1

Bivariate Multivariate

No
M (SD)/n (%)
Yes
M (SD)/n (%)
OR 95% CI p value AOR 95% CI p value
Sociodemographic characteristics
Age 25.3 (6.38) 26.3 (6.82) 1.02 1.00, 1.05 .096
Race
 Black 154 (33.4) 307 (66.6) REF REF
 Colored 27 (37.5) 45 (62.5) 0.81 0.49, 1.35 .424 0.72 0.40, 1.32 .292
 Other 14 (26.9) 38 (73.1) 1.40 0.74, 2.64 .306 1.39 0.62, 3.12 .427
Education
 Low 107 (40.2) 159 (59.8) REF
 High 87 (27.4) 231 (72.6) 1.79 1.26, 2.53 .001
Ever married 1.99 0.97, 4.08 .061
 No 185 (34.3) 354 (65.7)
 Yes 10 (20.8) 38 (79.2)
Country
 South Africa 115 (32.3) 241 (67.7) REF REF
 Botswana 7 (13.7) 44 (86.3) 3.40 1.50, 7.69 .003 2.82 1.10, 7.25 .031
 Namibia 54 (48.2) 58 (51.8) 0.45 0.30, 0.69 <.001 0.59 0.34, 1.01 .054
 Zimbabwe 19 (27.9) 49 (72.1) 1.32 0.76, 2.32 .327 1.08 0.52, 2.22 .843
Regular income
 No 112 (37.6) 186 (62.4) REF
 Yes 79 (28.2) 201 (71.8) 1.53 1.08, 2.18 .017
Medical Aid
 No 142 (38.4) 228 (61.6) REF
 Yes 51 (24.2) 160 (75.8) 1.95 1.34, 2.85 .001
Psychosocial characteristics
Sexual identity
 Lesbian or gay 151 (33.7) 297 (66.3) REF
 Other 42 (30.9) 94 (69.1) 1.14 0.75, 1.72 .540
Gender role identity
 Masculinity 2.61 (1.31) 2.55 (1.19) 0.96 0.84, 1.11 .611
 Femininity 2.77 (1.36) 3.01 (1.23) 1.16 1.01, 1.33 .038
Concealment of sexual orientation 2.15 (0.90) 2.02 (0.85) 0.84 0.69, 1.02 .074
Internalized homophobia 1.70 (0.70) 1.53 (0.64) 0.68 0.53, 0.88 .004
Sense of belonging
Sense of belonging to community 2.82 (0.65) 2.88 (0.66) 1.14 0.88, 1.49 .330
Sense of belonging to LGBT community 3.13 (0.62) 3.32 (0.58) 1.67 1.24, 2.24 .001
Sexual experience
No. of female partners in past 3 months
 0 partners 17 (27.0) 46 (73.0) REF REF
 1 partner 89 (28.6) 222 (71.4) 1.38 0.96, 1.97 .083 0.91 0.45, 1.86 .800
 2 or more partners 69 (38.5) 110 (61.5) 0.63 0.43, 0.92 .016 0.63 0.30, 1.35 .236
Consensual sex with man in past 3 months
 No 151 (31.1) 334 (68.9) REF
 Yes 44 (43.1) 58 (56.9) 0.60 0.39, 0.92 .020
Forced sex with women
 No 146 (29.6) 347 (70.4) REF
 Yes 49 (52.1) 45 (47.9) 0.39 0.25, 0.61 <.001
Forced sex with men
 No 139 (31.4) 303 (68.6) REF
 Yes 56 (38.6) 89 (61.4) 0.73 0.49, 1.08 .112
Transactional sex with women
 No 154 (30.9) 344 (69.1) REF
 Yes 41 (46.1) 48 (53.9) 0.52 0.33, 0.83 .006
Transactional sex with man
 No 170 (32.4) 355 (67.6) REF
 Yes 25 (40.3) 37 (59.7) 0.71 0.41, 1.20 .211
Sexual health
Ever received STI/HIV information specifically for WSM
 No 126 (35.1) 233 (64.9) REF
 Yes 69 (30.3) 159 (69.7) 1.25 0.87, 1.78 .226
STI knowledge 1.31 (0.69) 1.41 (0.71) 1.25 0.97, 1.60 .089
Knowledge about HIV transmission 7.17 (1.68) 7.65 (1.37) 1.23 1.09, 1.39 .001
Perceived risk of HIV
 No risk 119 (33.8) 233 (66.2) REF REF
 Some risk 70 (32.0) 149 (68.0) 1.09 0.76, 1.56 .649 1.52 0.96, 2.41 .074
No. of STI symptoms in past year 2.59 (2.60) 1.52 (1.88) 0.81 0.74, 0.88 <.001 0.78 0.70, 0.87 <.001
Diagnosed STI in past year
 No 179 (33.1) 362 (66.9) REF REF
 Yes 16 (34.8) 30 (65.2) 0.93 0.49, 1.75 .815 4.85 1.30, 9.82 .014
Ever tested for HIV
 No 60 (48.4) 64 (51.6) REF REF
 Yes 135 (29.2) 328 (70.8) 2.28 1.52, 3.42 <.001 2.36 1.45, 3.83 .001
Self-reported HIV status
 Positive 18 (43.9) 23 (56.1) REF
 Negative or don’t know 177 (32.4) 369 (67.6) 1.63 0.86, 3.10 .135
Mental distress
Frequency of alcohol consumption 1.77 (1.52) 1.66 (1.47) 0.95 0.84, 1.07 .413
Ever used drugs
 No drug 99 (33.8) 194 (66.2) REF
 Some drug use 96 (32.7) 198 (67.3) 1.05 0.75, 1.48 .770
Mental distress 2.23 (0.92) 2.07 (0.84) 0.81 0.66, 0.98 .032
Health Care
Being open about orientation to medical providers 2.72 (1.11) 2.82 (1.06) 1.10 0.93, 1.30 .281
Expected positive impact of disclosing orientation to medical provider 2.65 (1.10) 2.92 (1.03) 1.27 1.08, 1.50 .005
1.

Due to missing values, not all numbers add up to 591. For range of scale scores, see Table 1.